Effect of oral KETOPROFEN treatment in acute respiratory disease outbreaks in finishing pigs

Table 4 Clinical blood parameters (mean and standard deviation, sd) of representative pigs in a group of finishing pigs with respiratory clinical signs

Variable	Treatment group		DAY 0		DAY 3
		N	(Mean ± sd)	N	(Mean ± sd)
WBC (10⁹)	Placebo	74	24.4 ± 6.4	74	25.1 ± 6.3
WBC (10⁹)	Ketoprofen	75	23.1 ± 5.6	78	23.9 ± 5.3
HB (g/l)	Placebo	74	112.6 ± 10.0	74	110.9 ± 11.1
HB (g/l)	Ketoprofen	75	110.5 ± 12.1	78	112.0 ± 11.0
HCT (%)	Placebo	74	34.5 ± 4.5	74	34.6 ± 3.9
HCT (%)	Ketoprofen	75	34.5 ± 4.2	78	34.7 ± 3.7
PLT (1000/μl)	Placebo	74	394.8 ± 127.3	74	411.6 ± 112.3
PLT (1000/μl)	Ketoprofen	75	368.0 ± 115.3^a	78	414.3 ± 90.2^b

The pigs were given oral ketoprofen (3 mg/kg) or placebo during DAY 1–3 and sampled before treatment (DAY 0) and on the last day of treatment (DAY 3)
White blood cell count = WBC, haemoglobin = HG, haematocrit = HCT, platelet count = PLT
^a,bValues with different superscripts within the same row differ significantly, p ≤ 0.05

ISSN: 2055-5660